Catalyst Pharmaceuticals (CPRX) Assets Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.22% |
| Dec 31, 2025 | 41.83% |
| Sep 30, 2025 | 43.16% |
| Jun 30, 2025 | 49.21% |
| Mar 31, 2025 | 50.46% |
| Dec 31, 2024 | 49.93% |
| Sep 30, 2024 | 51.51% |
| Jun 30, 2024 | 55.28% |
| Mar 31, 2024 | 60.31% |
| Dec 31, 2023 | 50.72% |
| Sep 30, 2023 | 43.58% |
| Jun 30, 2023 | 42.98% |
| Mar 31, 2023 | 38.77% |
| Dec 31, 2022 | 34.48% |
| Sep 30, 2022 | 57.26% |
| Jun 30, 2022 | 49.34% |
| Mar 31, 2022 | 45.64% |
| Dec 31, 2021 | 41.64% |
| Sep 30, 2021 | 37.57% |
| Jun 30, 2021 | 33.71% |
| Mar 31, 2021 | 29.73% |
| Dec 31, 2020 | 26.20% |
| Sep 30, 2020 | 22.05% |
| Jun 30, 2020 | 13.97% |
| Mar 31, 2020 | 9.16% |
| Dec 31, 2019 | 20.68% |
| Sep 30, 2019 | 16.10% |
| Jun 30, 2019 | 11.24% |
| Mar 31, 2019 | 22.40% |
| Dec 31, 2018 | 18.96% |
| Sep 30, 2018 | 18.73% |
| Jun 30, 2018 | 42.72% |
| Dec 31, 2017 | 38.44% |
| Mar 31, 2017 | 49.85% |
| Dec 31, 2016 | 46.18% |
| Sep 30, 2016 | 60.18% |
| Jun 30, 2016 | 54.22% |
| Dec 31, 2015 | 59.45% |